XML 37 R21.htm IDEA: XBRL DOCUMENT
v3.22.0.1

Goodwill | 12 Months Ended
--- | ---
Dec. 31, 2021
Goodwill and Intangible Assets Disclosure [Abstract] |
Goodwill | (11) Goodwill The following are the changes in the carrying amount of goodwill by reporting unit:
| Year Ended December 31, 2021
| Healthcare |  | Industrial |  | Consolidated
(in thousands) | Gross Goodwill |  | Dispositions, Acquisitions and Impairments |  | Net Goodwill |  | Gross Goodwill |  | Dispositions, Acquisitions and Impairments |  | Net Goodwill |  | Gross Goodwill |  | Dispositions, Acquisitions and Impairments |  | Net Goodwill
Balance at beginning of year | $101,767 |  | $(32,055) |  | $69,712 |  | $134,382 |  | $(42,329) |  | $92,053 |  | $236,149 |  | $(74,384) |  | $161,765
Acquisition (a) | — |  | 39,182 |  | 39,182 |  | — |  | 170,033 |  | 170,033 |  | — |  | 209,215 |  | 209,215
Dispositions (b) | — |  | (15,598) |  | (15,598) |  | — |  | (3,873) |  | (3,873) |  | — |  | (19,471) |  | (19,471)
Adjustments (c) | (900) |  | — |  | (900) |  | 900 |  | — |  | 900 |  | — |  | — |  | —
Foreign currency translation adjustments | (2,481) |  | — |  | (2,481) |  | (3,440) |  | — |  | (3,440) |  | (5,921) |  | — |  | (5,921)
Total goodwill | $98,386 |  | $(8,471) |  | $89,915 |  | $131,842 |  | $123,831 |  | $255,673 |  | $230,228 |  | $115,360 |  | $345,588
a.The 2021 acquisition, for the Healthcare and Industrial segments in the table above relate to Allevi, Additive Works, Oqton and Volumetric. Approximately $560 of goodwill related to Allevi will be deductible for tax purposes. b.The 2021 dispositions for the Healthcare and Industrial segments in the table above relate to of ODM and Simbionix c.The 2021Adjustment, for the Healthcare and Industrial segments in the table above relate to reclassification within the segments. The following are the changes in the carrying amount of goodwill by reporting unit for 2020. This presentation reflects the prior year reporting unit structure, which has been changed for 2021. Due to unnecessarily burdensome procedures to recast this information into our new segment structure, we have taken the practicability exception allowed and presented as in prior year :
(in thousands) |  | Americas |  | EMEA |  | APAC |  | Total
Balance at December 31, 2019 |  | $ | — |  |  | $ | 186,695 |  |  | $ | 36,481 |  |  | $ | 223,176 |
Dispositions and impairments a |  | — |  |  | (69,685) |  |  | (4,699) |  |  | (74,384) |
Effect of foreign currency exchange rates |  | — |  |  | 10,582 |  |  | 2,391 |  |  | 12,973 |
Balance at December 31, 2020 |  | $ | — |  |  | $ | 127,592 |  |  | $ | 34,173 |  |  | $ | 161,765 |
a.Includes $21,385 of goodwill held for sale related to Cimatron in EMEA and $4,699 of goodwill related to the sale of our Australia ODM and Wuxi Easyway businesses in APAC. See Note 4. The effect of foreign currency exchange in the above tables reflect the impact on goodwill of amounts recorded in currencies other than the U.S. dollar on the financial statements of subsidiaries in these geographic areas resulting from the yearly effect of foreign currency translation between the applicable functional currency and the U.S. dollar. Our reporting units are Healthcare and Industrial. We completed the required annual goodwill impairment test as of November 30, 2021. The goodwill impairment test compared the fair value of each reporting unit to their carrying value. We estimated the fair value of our reporting units based primarily on projections of future revenues, expenses, and cash flows discounted to its present value, and a market approach. The valuation methodology and underlying financial information included in the Company's determination of fair value required significant judgment by management. The principal assumptions used in the Company's discounted cash flow analysis consisted of (a) the long-term projections of future financial performance and (b) the weighted-average cost of capital of market participants, adjusted for the risk attributable to the Company and the industry in which it operates. Under the market approach, the principal assumption included an estimate of multiples for various financial metrics of comparable companies. The estimated fair value for each of our reporting units was in excess of their respective carrying values as of November 30, 2021. As of September 30, 2020, we experienced a goodwill valuation triggering event due to a drop in our stock price, which was negatively impacted by the business environment as a result of the COVID-19 pandemic. Accordingly, we performed a quantitative analysis for potential impairment of our goodwill and long-lived asset balances. Based on available information and analysis as of September 30, 2020, we determined the carrying value of the EMEA reporting unit exceeded its fair value and recorded a non-cash goodwill impairment charge of $48,300. We determined the fair value of the Americas and APAC reporting units exceeded their carrying values and the carrying value of our long-lived assets is recoverable for all reporting units.

X
- References No definition available. + Details
Name: | us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for goodwill. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -SubTopic 20 -URI http://asc.fasb.org/subtopic&trid=2144439 + Details
Name: | us-gaap_GoodwillDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration